Posts

Bayer and Recursion expand oncology research partnership

Bayer has expanded a drug discovery research partnership with Recursion Pharmac...

EC approves Daiichi Sankyo’s Vanflyta for acute myeloid...

The European Commission (EC) has granted approval for Daiichi Sankyo’s Vanflyta...

FDA approves Takeda’s Adzynma for rare blood clotting d...

The US Food and Drug Administration (FDA) has granted approval for Takeda’s Adz...

Valneva wins FDA approval for the first chikungunya vac...

The US Food and Drug Administration (FDA) has granted accelerated approval to t...

Eli Lilly reiterates POINT acquisition plans with tende...

Eli Lilly has substantiated its desire to acquire radiopharmaceutical company P...

Innovations Powering the Future of mRNA: What Biomanufa...

It isn’t often that pharmaceutical advancements break out of laboratories to be...

STAT+: Vacancy rate in Boston-area lab space climbs to ...

As Massachusetts biotech companies face dwindling investments, it appears that t...

STAT+: After decades in use, heart stents finally beat ...

After decades in use, heart stents finally beat placebo. It took a bold researcher.

Wegovy cuts risk of heart attacks in milestone cardiova...

Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a la...

Opinion: What STAT’s opinion section is trying to do

How STAT's First Opinion section is trying to encourage more productive debate o...

U.K. recommendation could lead to world’s first use of ...

An expert panel that advises the United Kingdom on vaccine policy has recommende...

STAT+: What Amazon Prime’s new One Medical offering rev...

What Amazon Prime's new One Medical offering reveals about the future of health ...

STAT+: A Harvard-affiliated hospital is testing magic m...

A hospital affiliated with Harvard is testing whether hallucinogenic mushrooms c...

The first vaccine for the increasingly prevalent chikun...

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Novo Nordisk to spend $6 billion t...

Novo Nordisk announced a plan to spend a whopping $6 billion to expand its manuf...

STAT+: EU regulator recommends expanding diabetes drug ...

Two days after similar decisions in the U.S. and U.K., regulators in Europe on F...